Stepan/$SCL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Stepan

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Ticker

$SCL
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

2,396

ISIN

US8585861003

Stepan Metrics

BasicAdvanced
$1.2B
22.56
$2.45
1.00
$1.53
2.79%

What the Analysts think about Stepan

Analyst ratings (Buy, Hold, Sell) for Stepan stock.

Bulls say / Bears say

Stepan Company reported a significant earnings beat in Q1 2025, with earnings per share of $0.84 surpassing the consensus estimate of $0.51, indicating strong operational performance. (nasdaq.com)
Institutional investors have shown confidence in Stepan, with Norges Bank making a new $7.55 million investment in the company as of April 2025. (etfdailynews.com)
State Street Corp increased its holdings in Stepan by 1.5% in Q3 2024, reflecting positive sentiment from major financial institutions. (marketbeat.com)
In Q4 2024, Stepan reported earnings per share of $0.12, missing the consensus estimate of $0.35, which may raise concerns about the company's profitability. (nasdaq.com)
StockNews.com downgraded Stepan's stock rating from 'buy' to 'hold' in January 2025, suggesting potential caution among analysts regarding the company's future performance. (marketbeat.com)
Thrivent Financial for Lutherans reduced its holdings in Stepan as of March 2025, indicating a possible lack of confidence from institutional investors. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

Stepan Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Stepan Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SCL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs